Monthly injectable avermectin-class dewormers are used to prevent disease from meningeal worm in many camelid farms. This routine use raises concerns about anthelmintic (dewormer) resistance by gastrointestinal nematodes, such as Hemonchus, Nematodirus and others. The effect of routine use of injectable avermectin drugs on anthelmintic resistance in gastrointestinal parasites has not been systematically studied.
The specific aims of this study are:
To identify alpaca herds using monthly, parenteral avermectin-class dewormers to control meningeal worm and herds not using this method of prevention.
To determine the gastrointestinal nematode (GIN) burden of these herds and the anthelmintic susceptibility profile of those GIN.